Login

VC Firm investing in the lifesciences|Daniel Yadegar,Chief Medical Officer,Newpath Partners 00:10:00

Share On Facebook Share On Twitter

Daniel Yadegar is the Co-Founder and CMO of Newpath Management.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
CEO of Aspect BioSystems Tamer Mohamed speaks at the LSI USA '22 Emerging Medtech Summit | Tamer Mohamed, PRESIDENT & CEO, ASPECT BIOSYSTEMS LTD
00:10:00
Top Credit Cards for Cash and Travel Rewards with Eric Simonson, CFP | Eric Simonson - CEO of Abundo Wealth
00:10:00
We help the daring build legendary companies from idea to IPO and beyond the market|Luciana Lixandru,partner,Sequoia
00:10:00
SM Ventures into Logistics with 2GO Express, Inc. | Mr. Frederic C. Dybuncio - President/Chief Executive Officer at 2go group inc
00:10:00
Market Insight: External Asset Management Trends - Stephan Aepli, Head of External Asset Managers at REYL Intesa Sanpaolo
00:10:00
Chalice Gold Mines: Exploring New Frontiers in Victoria and Quebec
00:10:00
Melanie Perkins, Canva CEO, transformed her small Australian college startup into a global unicorn.
00:10:00
This venture capitalist chooses start-ups for investments|Oren Zeev,Founding Partner,Zeev Ventures
00:10:00
Silver Market Insights and Future Outlook with Sean Konun
00:10:00
Bille's Story: Justice After 30 Years |
00:10:00
Vior's Hybrid Prospect Generator Model and Belter Gold Project Plans for 2024
00:10:00
Kiliaro Group AB CEO Elie Komo on the Acquisition of Sosyopix | Elie Komo, CEO, Kiliaro Group AB.

© 2017 - Neuhu+